close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cardinal Health (NY:CAH)

157.72 +0.45 (+0.29%)
Streaming Delayed Price Updated: 2:07 PM EDT, Oct 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cardinal Health

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Robinhood To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Thursday
 
Via Benzinga
Wall Street Battles For Fifth Day Of Gains As Inflation Cools, Gives Green Light To Rate Cuts; Financials Outperform: What's Driving Markets Wednesday?
The July consumer inflation report released Wednesday confirmed a continued cooling trend in price increases across the economy, with the headline Consumer Price Index (CPI) coming in at 2.9%... 
Via Benzinga
Topics Economy
Stocks To Watch Today: Alphabet, Cardinal Health, And Kellanova
Alphabet faces a potential breakup by the DOJ, causing its shares to tumble; Cardinal Health rises on strong earnings and improved guidance; and Kellanova surges following news of its acquisition by... 
Via Talk Markets
How To Earn $500 A Month From Cardinal Health Stock Ahead Of Q4 Earnings
 
Via Benzinga
$1000 Invested In Cardinal Health 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
How Is The Market Feeling About Cardinal Health?
 
Via Benzinga
CAH Stock Earnings: Cardinal Health Beats EPS, Beats Revenue for Q4 2024
CAH stock results show that Cardinal Health beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
S&P 500 Rises, Small Caps Outperform As July Consumer Price Index Fuels Fed Rate Cut Hopes: 5 ETFs to Watch Wednesday
US inflation eases in July, keeping Fed rate cut hopes alive. Stocks rise, yields stable, dollar gains against yen. Tech and small caps outperform. 
Via Benzinga
Topics ETFs Economy Stocks
Cardinal Health Reports Double Beat In Fiscal Q4
Cardinal Health has reported impressive fourth-quarter and fiscal year 2024 results, surpassing market expectations. 
Via Talk Markets
Top 3 Health Care Stocks That May Crash In August
 
Via Benzinga
Cardinal Health Poised To Retake Key Level On Bullish Fiscal 2025 View
Cardinal Health reported better-than-expected fiscal fourth-quarter earnings and hiked 2025 profit expectations 
Via Investor's Business Daily
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,000 Today
 
Via Benzinga
$1000 Invested In Cardinal Health 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Here's How Much $1000 Invested In Cardinal Health 5 Years Ago Would Be Worth Today
 
Via Benzinga
Pharma Distribution Giant Cardinal Health Lifts 2025 Guidance After Q4 Earnings Beat, Raises Stock Buyback Expectation By $250M
Cardinal Health reports Q4 2024 EPS of $1.84, beating estimates. Sales surged 12% to $59.87 billion, driven by strong pharmaceutical and medical segment growth. The company raises FY 2025 EPS guidance... 
Via Benzinga
Topics Earnings
Wall Street Set For Subdued Start As Traders Await All-Important Inflation Data, Bitcoin Tops $61K: Fund Manager Flags This Event As Pivotal To Near-term Market Recovery
The major index futures are pointing to a nervous start ahead of the consumer price inflation report that is due at 8:30 a.m. EDT. Bond yields are slipping ahead of the inflation data. 
Via Benzinga
Topics Economy
Nasdaq, Dow Jones Jump Over 400 Points Following PPI Report: Investor Sentiment Improves But Greed Index Remains In 'Extreme Fear' Zone
 
Via Benzinga
Topics Stocks
Brinker International, Cisco And 3 Stocks To Watch Heading Into Wednesday
 
Via Benzinga
How Is The Market Feeling About Cardinal Health?
 
Via Benzinga
Cardinal Health Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
 
Via Benzinga
Health Care Giant McKesson Dives Amid Big Revenue Miss
McKesson earnings beat estimates, but the drug and health supplies distribution giant badly missed sales estimates. MCK stock dived. 
Via Investor's Business Daily
Topics Earnings
Medical Technology Stock Benefits from Rising Acute Care Demand
Medical and surgical products manufacturer Stryker Co. (NYSE: SYK) is a beneficiary of the acute care boom occurring in the healthcare industry. 
Via MarketBeat
Topics Supply Chain
The 7 Most Undervalued Dividend Stocks to Buy in July 2024
For nearly 100 years income stocks have outperformed the market and these three undervalued dividend stocks are your best buys this month. 
Via InvestorPlace
From Lab Rats And Eyeballs To Cannabis: Scarlet Express CEO Discusses Closed-Loop Delivery, How To 'Survive In Chaos'
Claudia Post launched Scarlet Express, a state-approved, closed-loop delivery organization providing expert cannabis supply chain management. 
Via Benzinga
Topics Cannabis Economy
Drug Distributor Cencora Falls; Blame Walgreens, Not The Supreme Court
Cencora stock and other drug distributors fell on Wednesday, hit by Walgreens results, not the ruling that killed an opioid settlement. 
Via Investor's Business Daily
NYSE:CAH appears to be flying under the radar despite its strong fundamentals.
In a market where value is scarce, CARDINAL HEALTH INC (NYSE:CAH) offers a refreshing opportunity with its solid fundamentals. 
Via Chartmill
The Dividend Dynasty: 3 Stocks That Will Keep Your Pockets Lined for Years
While AI stocks grab headlines, dividend stocks quietly offer stability. Explore why these three are top choices for a secure portfolio. 
Via InvestorPlace
Topics Artificial Intelligence
In a market where value is scarce, NYSE:CAH offers a refreshing opportunity with its solid fundamentals.
CARDINAL HEALTH INC (NYSE:CAH) is an undervalued gem with solid fundamentals. 
Via Chartmill
Bulletproof Your Retirement: 3 Stocks That Will Stand the Test of Time
Protect and grow your assets with these stable, retirement-proof stocks, which will deliver earnings growth and shareholder returns. 
Via InvestorPlace
UnitedHealth's OptumRx Unveils New Transparent Drug Pricing Initiative for 2024
UnitedHealth's OptumRx will implement a new pricing model, OptumRx Clear Trend Guarantee, starting next year. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today